exoASO-STAT3

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameexoASO-STAT3
Drug Alias NameexoASO-STAT3
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsRNA interference
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsHematologic NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodiak Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesCodiak Biosciences
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A